Cure My Disease

Don't miss your cure!

 Log in / Sign up

New imaging combo could sharpen radiation for esophageal cancer

NCT ID NCT05796102

Recruiting now Knowledge-focused Sponsor: University Health Network, Toronto Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a combined PET-MRI scan can help doctors plan radiation treatment more precisely for people with esophagogastric cancer. Fifteen participants will receive PET-MRI scans before, during, and after radiation therapy. The images will not be used for their actual treatment—instead, researchers will compare them to standard scans to see if PET-MRI provides better tumor visualization. The goal is to gather information for future use, not to change current care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
PET-MRI scan
What this could lead to
If successful, this could help doctors use PET-MRI to better target radiation therapy for esophageal cancer, potentially improving treatment accuracy.
What could go wrong
This is a very small, early feasibility study with only 15 people. It is not designed to test whether PET-MRI actually improves outcomes, only whether it can be used in the workflow.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

esophageal cancer gastroesophageal cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ESOPHAGOGASTRIC CANCER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Princess Margaret Cancer Centre

    RECRUITING

    Toronto, Ontario, Canada

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.